Details
- Start Date: March 2024
- Phase: Phase 3
- Insurance: No insurance is needed
- Benefits: Medication for weight loss and compensation up to $2,000
Obesity is a serious chronic health condition that affects body weight, metabolism, and overall health for many patients worldwide. Clinical trials help advance the treatment of obesity by testing new medications, therapies, and lifestyle interventions under licensed health care professionals.
Study-related visits and exams with a physician are provided at no cost. Participants may also receive compensation for time and travel.
Enroll Now
Santos Research Center invites individuals to participate in a pivotal Phase 3 clinical trial focused on innovative treatment methods for obesity.
This trial is part of a comprehensive research initiative to develop more effective strategies for weight management and overall health improvement.
Study-related phone and in-clinic visits with Physician at no cost
Clinical trials are essential for improving how obesity is treated and managed. These studies test the safety and effectiveness of new medications, therapies, and lifestyle approaches to support healthier weight and reduce obesity-related health risks.
By joining a research study, you can:
These benefits are general. Each study is different, and details will be fully reviewed during the informed consent process.
You will have a phone call with the research team to discuss your health history, weight and BMI, and general eligibility criteria for the study.
If you qualify, you will visit the clinic to meet the care team, review the informed consent form, and complete health assessments such as physical exams or lab tests as required by the study protocol.
If enrolled, you will follow the study procedures, which may include investigational treatments, lifestyle or nutrition guidance, or other research activities. The team will monitor your health and progress to ensure safety throughout participation.
These steps are general and may vary by study. Full details about procedures, risks, and benefits will be reviewed with you during the informed consent process. Participation is always voluntary.
Santos Research Center is led by licensed physicians with experience in psychiatry, neurology, and clinical research. All studies are IRB-approved and comply with FDA guidelines. Bilingual staff ensure clear communication for all participants. About Us
Help advance obesity research and improve future health care options. If you qualify, you can access no-cost, study-related care and may receive compensation for your time and travel. Participation is always voluntary, and your safety and comfort are our top priorities.
Get access to new treatments by participating
Obesity is a chronic disease defined by excessive body fat (body mass index [BMI] >=30) that can negatively impact health. It affects millions of adults in the United States and worldwide.
Causes of obesity are complex and include:
Health risks linked to obesity include:
Treatments for obesity may involve:
Current research focuses on:
This information is for general educational purposes. Specific details about any clinical trial at Santos Research Center will be reviewed during the informed consent process.
Patients trust Santos Research Center for compassionate care, professional staff, and a welcoming environment.
"Very professional. The coordinators and doctors treat you like family."
Reinaldo S.Newer weight loss treatments include GLP-1 receptor agonists like semaglutide and tirzepatide. These medications regulate appetite, body weight, and blood sugar, and are used alongside dietitian-guided nutrition plans, physical activity, and behavior therapy to support healthy weight management.
Recent drugs approved for obesity include semaglutide (Wegovy) and tirzepatide (Mounjaro). Both belong to medication classes that affect hormones like GLP-1 to reduce appetite and improve metabolism. Ongoing randomized controlled trials continue to assess their efficacy and long-term safety.
Compensation varies by clinical trial, location, and activities involved. Some obesity clinical trials pay participants for time, travel, BMI measurements, and health evaluations, while providing study-related health care at no cost.
Current medical research focuses on developing new medications, understanding genetic and hormone-related causes, studying body mass index (BMI) trends, and evaluating combination therapy approaches such as medication plus lifestyle interventions. Studies also assess cardiovascular disease risk, type 2 diabetes prevention, and long-term effects of treatments like bariatric surgery.
Type 3 obesity, also known as class 3 or severe obesity, is defined as having a BMI of 40 or higher. This classification carries the highest risk for complications like hypertension, heart disease, chronic kidney disease, and sleep apnea.
Weight loss is complex. It involves metabolism, hormones like leptin and insulin, genetics, mental health factors, diet, physical activity levels, and environmental factors such as food availability. Obesity is recognized as a chronic disease by the World Health Organization and the American Association of Clinical Endocrinology.
Effective treatment combines nutrition, calorie management, physical activity, and behavioral therapy. For some patients, weight loss medication or bariatric surgery options may be recommended by physicians to improve health outcomes and reduce mortality rate.
Common signs and symptoms include high BMI, increased waist circumference, shortness of breath during activity, joint pain or back pain due to excess weight, and fatigue or low energy.
A measure of body fat based on height and weight.
A type of medication that helps control blood sugar and appetite.
Medications used for obesity and type 2 diabetes management.
An inactive substance used to compare effects against the study medication.
The process of learning about a study and agreeing to participate voluntarily.
Severe obesity defined as a BMI of 40 or higher.
Surgical procedures to help with weight loss, such as gastric bypass or sleeve gastrectomy.
A surgery that reduces stomach size and reroutes digestion to aid weight loss.
A surgery that removes part of the stomach to help reduce food intake and weight.
Hormones that help regulate hunger, metabolism, and blood sugar.
A type of clinical study where participants are randomly assigned to different groups to test a treatment.
The process your body uses to convert food into energy.
Health of the heart and metabolism, including risks like diabetes and high blood pressure.
A committee that reviews clinical trials to ensure participant safety and ethical standards.
Other health conditions that often occur alongside obesity, like diabetes or hypertension.
High blood pressure, which increases risk for heart disease and stroke.
A condition where the body struggles to regulate blood sugar effectively.